Sarepta Therapeutics (SRPT) Tax Provisions (2017 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Tax Provisions of $12.2 million for Q1 2026, down 80.94% year-over-year from $64.0 million in Q1 2025, and up 166.09% quarter-over-quarter from $4.6 million in Q4 2025.
Sarepta Therapeutics (SRPT) Tax Provisions (2017 - 2026) Analysis & Trends
Sarepta Therapeutics' Tax Provisions history runs 10 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 80.94% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at -$40.6 million (down 148.09% YoY), while the FY2025 annual figure was $11.2 million, down 56.62% from the prior year.
- Tax Provisions for Q1 2026 stood at $12.2 million, up from $4.6 million in the prior quarter.
- The five-year high for Tax Provisions was $64.0 million in Q1 2025, with the low at -$43.3 million in Q2 2025.
- The 5-year median for Tax Provisions is $4.6 million (2025), against an average of $4.6 million.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions surged 1879.55% in 2022, then slumped 3670.13% in 2025.
- Sarepta Therapeutics' Tax Provisions stood at $7.9 million in 2022, then slumped by 164.49% to -$5.1 million in 2023, then soared by 352.84% to $12.9 million in 2024, then slumped by 64.58% to $4.6 million in 2025, then jumped by 166.09% to $12.2 million in 2026.
- Business Quant data shows SRPT's Tax Provisions at $12.2 million in Q1 2026, $4.6 million in Q4 2025, and -$14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 3.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.14 Mn |
| Mar 31, 2026 | 12.20 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | -14.10 Mn |
| Jun 30, 2025 | -43.30 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Sep 30, 2024 | 395,000.00 |
| Jun 30, 2024 | 7.12 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | -5.12 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 9.36 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 7.94 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 3.39 Mn |
| Mar 31, 2022 | 879,000.00 |
| Dec 31, 2021 | 401,000.00 |
| Sep 30, 2021 | 237,000.00 |